Alzex Neuropharma Inc.

Alzex Neuropharma Inc.

TRRI
Alzex Neuropharma Inc.US flagOther OTC
0.00
USD
- -
- -
602.00Market Cap
Alzex Neuropharma Inc.
TRRI
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Trinity Resources Inc. (OTC: TRRI) engages in the exploration and development of natural resource interests, focusing on acquiring mineral concessions and properties rich in gold, silver, and platinum group metals across North and South America; the company targets precious and strategic metal projects in mining-friendly jurisdictions. Founded on March 11, 1971 and headquartered in Las Vegas, Nevada, with key contacts at 8275 S. Eastern Avenue, Suite 200-168, Trinity operates primarily in the Americas, serving institutional investors and mining sector partners through early-stage exploration and development activities. No major acquisitions, partnerships, funding rounds, or product launches have been announced in the last 1-2 years, reflecting a focus on core property evaluation amid market conditions for precious metals.